| 摘要 |
Medicaments in a form suitable for systemic administration contain 16-methyl, 16,16-dimethyl-, 16-ethyl-, 16,16-diethyl- or 16-methyl-16-ethyl-PGE, -PGE2, -PGA1 or -PGA2 in their optically active or racemic forms, or their salts or 1-8C-alkyl esters. Compsns. are capable of ggiving a dose of 0.7-57 mg/kg PG. Thus a capsule contg. 2mg 16,16-dimethyl PGE2 given 1-4 times daily reduces the secretion of gastric juices in a patient showing gastric hypersecretion. |
